Is This the Biggest Threat to GW Pharmaceuticals' Marijuana Drug?

The FDA and DEA have signed off on GW Pharmaceuticals' marijuana treatment for epilepsy, but its sales could stall if this other treatment nabs a regulatory OK.
The move could be aimed at protecting investors, who helped him buy purchase X, from losing money. from BBC News https://ift.tt/upf7MHS
0 comments:
Post a Comment